• Profile
Close

Photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL) improves outcomes of treatment-resistant infectious keratitis

Clinical Ophthalmology Dec 23, 2020

Gulias-Cañizo R, Benatti A, De Wit-Carter G, et al. - In this observational cohort study, researchers sought to examine the effectiveness of photoactivated chromophore corneal collagen cross-linking (PACK)-CXL in the management of treatment-resistant infectious keratitis. The sample consisted of 41 patients (42 eyes) with treatment-resistant infectious keratitis. The success rate was 90.5% in the third postoperative month. Statistical analyses exhibited a significant effect of (PACK)‑CXL with standard antimicrobial therapy to reduce corneal ulcer size. PACK-CXL improves the outcomes in patients with treatment-resistant corneal ulcers as adjuvant therapy to standard antimicrobial treatment.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay